What is the relative efficacy and tolerability of Antipsychotic Polypharmacy and High Dose Antipsychotic Therapy compared to the use of Antipsychotic Monotherapy at standard doses in the treatment of Schizophrenia?
What is the relative efficacy and tolerability of Antipsychotic Polypharmacy and High Dose Antipsychotic Therapy compared to the use of Antipsychotic Monotherapy at standard doses in the treatment of Schizophrenia?
Lawrence, Christopher
9f61058b-220f-4bfa-a9fb-b33a7af1dda2
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Chamberlain, Samuel
8a0e09e6-f51f-4039-9287-88debe8d8b6f
23 July 2023
Lawrence, Christopher
9f61058b-220f-4bfa-a9fb-b33a7af1dda2
Hou, Ruihua
470bdcbc-93a9-4dad-aac5-26d455c34376
Chamberlain, Samuel
8a0e09e6-f51f-4039-9287-88debe8d8b6f
Lawrence, Christopher, Hou, Ruihua and Chamberlain, Samuel
(2023)
What is the relative efficacy and tolerability of Antipsychotic Polypharmacy and High Dose Antipsychotic Therapy compared to the use of Antipsychotic Monotherapy at standard doses in the treatment of Schizophrenia?
British Association of Psychopharmacology Summer Meeting 2023, University of Manchester, Manchester, United Kingdom.
23 - 28 Jul 2023.
Record type:
Conference or Workshop Item
(Poster)
Text
HDAT APP Protocol Poster Christopher Lawrence
- Version of Record
More information
Published date: 23 July 2023
Venue - Dates:
British Association of Psychopharmacology Summer Meeting 2023, University of Manchester, Manchester, United Kingdom, 2023-07-23 - 2023-07-28
Identifiers
Local EPrints ID: 481182
URI: http://eprints.soton.ac.uk/id/eprint/481182
PURE UUID: 283fe9e5-8e26-405b-9cd8-65e4ab2f14b5
Catalogue record
Date deposited: 17 Aug 2023 16:56
Last modified: 18 Mar 2024 03:58
Export record
Contributors
Author:
Christopher Lawrence
Author:
Samuel Chamberlain
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics